Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Marc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, Frederico LA Fernandes, Jorge Dreyse, José R Jardim, Siwasak Juthong, Gur Levy & Martin Sivori. (2023) Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1853-1866.
Read now
Read now
Michael Bogart, Guillaume Germain, François Laliberté, Dominique Lejeune & Mei Sheng Duh. (2023) Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1575-1586.
Read now
Read now
Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Read now
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Rosa Annibale, Francesco Russo & Mario Cazzola. (2021) Classes of drugs that target the cellular components of inflammation under clinical development for COPD. Expert Review of Clinical Pharmacology 14:8, pages 1015-1027.
Read now
Read now
Articles from other publishers (5)
A. Roque, L. Taborda-Barata, Á.A. Cruz, G. Viegi & T. Maricoto. (2023) COPD treatment – a conceptual review based on critical endpoints. Pulmonology 29:5, pages 410-420.
Crossref
Crossref
Matthew Mintz, Igor Barjaktarevic, Donald A. Mahler, Barry Make, Neil Skolnik, Barbara Yawn, Bree Zeyzus-Johns & Nicola A. Hanania. (2023) Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clinic Proceedings 98:2, pages 301-315.
Crossref
Crossref
So-Won Park, A Yeong Lee, Je-Oh Lim, Se-Jin Lee, Woong-Il Kim, Yea-Gin Yang, Bohye Kim, Joong-Sun Kim, Sung-Wook Chae, Kun Na, Yun-Soo Seo & In-Sik Shin. (2022) Loranthus tanakae Franch. & Sav. Suppresses Inflammatory Response in Cigarette Smoke Condensate Exposed Bronchial Epithelial Cells and Mice. Antioxidants 11:10, pages 1885.
Crossref
Crossref
Paolo Solidoro, Carlo Albera, Fulvia Ribolla, Michela Bellocchia, Luisa Brussino & Filippo Patrucco. (2022) Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?. Frontiers in Medicine 9.
Crossref
Crossref
Nightingale Syabbalo. (2021) The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease. Journal of Lung, Pulmonary & Respiratory Research 8:3, pages 96-102.
Crossref
Crossref